Invera Wealth Advisors LLC Reduces Position in UnitedHealth Group Incorporated (NYSE:UNH)

Invera Wealth Advisors LLC decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.5% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,840 shares of the healthcare conglomerate’s stock after selling 74 shares during the quarter. UnitedHealth Group makes up 1.5% of Invera Wealth Advisors LLC’s holdings, making the stock its 23rd largest holding. Invera Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $1,505,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of UNH. Boston Financial Mangement LLC boosted its stake in shares of UnitedHealth Group by 3.9% during the 4th quarter. Boston Financial Mangement LLC now owns 8,660 shares of the healthcare conglomerate’s stock worth $4,381,000 after purchasing an additional 324 shares during the period. First Bank & Trust boosted its stake in shares of UnitedHealth Group by 9.5% during the 4th quarter. First Bank & Trust now owns 1,383 shares of the healthcare conglomerate’s stock worth $700,000 after purchasing an additional 120 shares during the period. Advyzon Investment Management LLC purchased a new position in shares of UnitedHealth Group during the 4th quarter worth about $994,000. WealthBridge Capital Management LLC boosted its stake in shares of UnitedHealth Group by 1.2% during the 4th quarter. WealthBridge Capital Management LLC now owns 1,965 shares of the healthcare conglomerate’s stock worth $994,000 after purchasing an additional 23 shares during the period. Finally, Sunpointe LLC increased its position in shares of UnitedHealth Group by 6.5% during the fourth quarter. Sunpointe LLC now owns 2,930 shares of the healthcare conglomerate’s stock worth $1,482,000 after acquiring an additional 179 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 0.33% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on UNH. Wells Fargo & Company decreased their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Truist Financial decreased their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. Barclays cut their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a report on Friday, January 17th. Finally, StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Trading Up 2.0 %

NYSE UNH opened at $510.75 on Thursday. The company has a fifty day moving average of $520.62 and a 200 day moving average of $561.67. The company has a market capitalization of $470.03 billion, a PE ratio of 32.95, a P/E/G ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company’s revenue was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $5.83 earnings per share. Research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.